Genetics & Genomics

Empowering the Patient Voice: Genomic Testing and Cancer Care Decisions

In this roundtable discussion presented by AONN+ and supported by Exact Sciences, a panel of experts discuss the critical role of nurse navigators in educating cancer patients about genomic testing and how to interpret the results.

Opportunities Are Abundant for Navigators in the Field of Genetics and Genomics

Dr Andrey Antov sees much potential for navigators when it comes to applying genetic and genomic testing to cancer care.

The Navigator's Role in Genetic Testing

Dr Andrey Antov recognizes how important the role of the navigator is in dealing with genetic and genomic testing, as the navigator often needs to help the patient gain access to the appropriate therapy, work with different stakeholders, monitor data, and more.

Educating Oncology Professionals on Genetic and Genomic Testing

Dr Andrey Antov provides an overview of the role of Jackson Laboratory in the field of cancer genetic testing and in the education of nurses and navigators who co-manage patients at high risk or with a diagnosis of cancer.

The Future of Genomics and Targeted Therapies

Dr Andrey Antov muses on the evolution of genomics and how it could potentially impact targeted therapies and cancer care.

Who Should Consider Genetic Testing?

Dr Andrey Antov identifies situations in which people may want to consider genetic testing.

Genetic vs Genomic Testing: What's the Difference?

Dr Andrey Antov provides a useful metaphor to explain how genetic testing and genomic testing differ from one another and the purpose behind each type of testing.

Misconceptions About Genetic and Genomic Testing

Dr Andrey Antov notes that there is often confusion around genetic and genomic testing, due in part to a lack of genetic counselors, high costs, and the rate of adoption of new technologies.